The global blood-brain barrier market projected to reach US$ 5,704.2 Mn by 2026 from US$ 696.4 Mn in 2017, growing at a CAGR of 25.0% during the forecast period from 2018 to 2026. The blood-brain barrier (BBB) prevents free flow of elements from circulatory system to the cerebrospinal fluid (CSF) or brain with specific exchange of elements regulated by blood-brain barrier and blood-CSF barrier.
Short bowel syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. The individuals with short bowel syndrome exhibit poor absorption of nutrients such as water, fats, carbohydrates, vitamins, minerals and other vital elements which leads to malnutrition, weight loss.
Aplha mannosidosis is a rare genetic disorder belonging to a group of diseases known as lysosomal storage disorders. Aplha mannosidosis occurs in 1 in every 500,000 people in the general population and is characterized by a deficiency of the enzyme alpha-D-mannosidase. The symptoms, progression and severity of alpha-mannosidosis vary widely from one person to another, including between siblings who share the same mutation.
The actinic keratosis (AK) treatment market is anticipated to grow at a CAGR of about 4.5% during the forecast period 2022-2030. In skin care, occurrence of rough, scaly, crusty, thick patches on the skin surface showing premalignant condition is referred as actinic keratosis.
This report on global glioblastoma multiforme market studies various drugs used for treatment of glioblastoma along with pipeline analysis of upcoming potential drugs. Glioblastoma multiforme is the most common and most aggressive cancer that begins within the brain. According to Brain Tumour Foundation of Canada, The incidence of glioblastoma multiforme (GBM) is 2 to 3 per 100,000 people in the United States and Europe. GBM accounts for 12 to 15% of all intracranial tumours and 50 to 60 per cent of astrocytic tumours.
Diseases & Conditions Market Research Reports
The worldwide market figure for infectious diseases & conditions plus vaccines, diagnostic and pharmaceutical items was evaluated at fifty nine billion dollars in year 2011. This is further estimated to reach a figure of ninety seven billion dollar by year 2017 at a CAGR growth rate of about 8 %. Diseases & Conditions market also covers the market size and market projection for medical equipments as well as treatment of diseased condition.
Since last few years, the knowledge, understanding and diagnosis of the diseases & conditions have improved. The diseases & conditions industry has witnessed a constant growth & expansion in USA and other universal business markets. Also the healthcare sector and the pharmaceuticals industry have been constantly exhibiting best outcomes by regularly implementing effective changes in its procedures, protocols & policies.
Our diseases & conditions market research reports offer key concepts regarding various aspects of specific illness, its cure and problems associated to it. It provides an outline of the illness and relative conditions with related occurrence, mortality numbers and huge proportions for prominent business friendly as well as business promoting nations globally.
Market research reports of Acute Market Reports include market trend analysis, ratio analysis, profit analysis, cost benefit market analysis, SWOT analysis, value chain analysis, PESTEL analysis, porter five force analysis, sales forecasting, product analysis, portfolio analysis, bench markeing, market positioning and product branding.
It also offers the market overview, financial and business overview of the market to its customers which helps them to take the correct business decisions and actions resulting in growth & expansion of their business.